<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.1d3" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0166942</article-id>
<article-id pub-id-type="publisher-id">PONE-D-16-24539</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical microbiology</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Immunodeficiency viruses</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Immunodeficiency viruses</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Immunodeficiency viruses</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Immunodeficiency viruses</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>RNA viruses</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical microbiology</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Public and occupational health</subject><subj-group><subject>Preventive medicine</subject><subj-group><subject>HIV prevention</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pharmacology</subject><subj-group><subject>Drug screening</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Social sciences</subject><subj-group><subject>Sociology</subject><subj-group><subject>Sexual and gender issues</subject><subj-group><subject>Sex work</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Public and occupational health</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pharmacology</subject><subj-group><subject>Drug research and development</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Health care</subject><subj-group><subject>Health services research</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Infectious diseases</subject><subj-group><subject>Viral diseases</subject><subj-group><subject>HIV infections</subject></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Uptake of Community-Based Peer Administered HIV Point-of-Care Testing: Findings from the PROUD Study</article-title>
<alt-title alt-title-type="running-head">Uptake of Community-Based HIV POCT</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>Lazarus</surname>
<given-names>Lisa</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Patel</surname>
<given-names>Sheetal</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Shaw</surname>
<given-names>Ashley</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Leblanc</surname>
<given-names>Sean</given-names>
</name>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Lalonde</surname>
<given-names>Christine</given-names>
</name>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Hladio</surname>
<given-names>Manisha</given-names>
</name>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Mandryk</surname>
<given-names>Kira</given-names>
</name>
<xref ref-type="aff" rid="aff005"><sup>5</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Horvath</surname>
<given-names>Cynthia</given-names>
</name>
<xref ref-type="aff" rid="aff005"><sup>5</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Petrcich</surname>
<given-names>William</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Kendall</surname>
<given-names>Claire</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff006"><sup>6</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Tyndall</surname>
<given-names>Mark W.</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff007"><sup>7</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<collab>for the Proud Community Advisory Committee</collab>
<xref ref-type="fn" rid="fn001"><sup>¶</sup></xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Ottawa Hospital Research Institute, Ottawa, Canada</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>PROUD Community Advisory Committee, Ottawa, Canada</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>Drug Users Advocacy League, Ottawa, Canada</addr-line></aff>
<aff id="aff004"><label>4</label> <addr-line>Department of Medicine, University of Ottawa, Ottawa, Canada</addr-line></aff>
<aff id="aff005"><label>5</label> <addr-line>Ottawa Public Health, Ottawa, Canada</addr-line></aff>
<aff id="aff006"><label>6</label> <addr-line>CT Lamont Primary Health Care Research Centre, Bruyere Research Institute, Department of Family Medicine, University of Ottawa, Ottawa, Canada</addr-line></aff>
<aff id="aff007"><label>7</label> <addr-line>University of Ottawa at the Ottawa Hospital, Division of Infectious Diseases, Ottawa, Canada</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Petoumenos</surname>
<given-names>Kathy</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>University of New South Wales, AUSTRALIA</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="con">
<p><list list-type="simple">
<list-item><p><bold>Conceptualization:</bold> LL AS SL KM CH CK MWT.</p></list-item>
<list-item><p><bold>Formal analysis:</bold> LL SP AS WP MWT.</p></list-item>
<list-item><p><bold>Funding acquisition:</bold> MWT.</p></list-item>
<list-item><p><bold>Methodology:</bold> LL SP AS SL KM CH CK MWT.</p></list-item>
<list-item><p><bold>Software:</bold> SP WP.</p></list-item>
<list-item><p><bold>Writing – original draft:</bold> LL.</p></list-item>
<list-item><p><bold>Writing – review &amp; editing:</bold> LL SP AS SL CL MH KM CH WP CK MWT.</p></list-item></list>
</p>
</fn>
<fn fn-type="other" id="fn001">
<p>¶ PROUD Community Advisory Committee members are thanked in the Acknowledgments</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">lis_laz@yahoo.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>2</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<volume>11</volume>
<issue>12</issue>
<elocation-id>e0166942</elocation-id>
<history>
<date date-type="received">
<day>18</day>
<month>6</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>6</day>
<month>11</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-year>2016</copyright-year>
<copyright-holder>Lazarus et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0166942"/>
<abstract>
<sec id="sec001">
<title>Objectives</title>
<p>HIV prevalence among people who inject drugs (PWID) in Ottawa is estimated at about 10%. The successful integration of peers into outreach efforts and wider access to HIV point-of-care testing (POCT) create opportunities to explore the role of peers in providing HIV testing. The PROUD study, in partnership with Ottawa Public Health (OPH), sought to develop a model for community-based peer-administered HIV POCT.</p>
</sec>
<sec id="sec002">
<title>Methods</title>
<p>PROUD draws on community-based participatory research methods to better understand the HIV risk environment of people who use drugs in Ottawa. From March-October 2013, 593 people who reported injecting drugs or smoking crack cocaine were enrolled through street-based recruitment. Trained peer or medical student researchers administered a quantitative survey and offered an HIV POCT (bioLytical INSTI test) to participants who did not self-report as HIV positive.</p>
</sec>
<sec id="sec003">
<title>Results</title>
<p>550 (92.7%) of the 593 participants were offered a POCT, of which 458 (83.3%) consented to testing. Of those participants, 74 (16.2%) had never been tested for HIV. There was no difference in uptake between testing offered by a peer versus a non-peer interviewer (OR = 1.05; 95% CI = 0.67–1.66). Despite testing those at high risk for HIV, only one new reactive test was identified.</p>
</sec>
<sec id="sec004">
<title>Conclusion</title>
<p>The findings from PROUD demonstrate high uptake of community-based HIV POCT. Peers were able to successfully provide HIV POCT and reach participants who had not previously been tested for HIV. Community-based and peer testing models provide important insights on ways to scale-up HIV prevention and testing among people who use drugs.</p>
</sec>
</abstract>
<funding-group>
<funding-statement>Funding has been received for this work from the Canadian Institutes of Health Research (FRN 134048; <ext-link ext-link-type="uri" xlink:href="http://www.cihr-irsc.gc.ca/e/193.html" xlink:type="simple">http://www.cihr-irsc.gc.ca/e/193.html</ext-link>), the Ontario HIV Treatment Network (<ext-link ext-link-type="uri" xlink:href="http://www.ohtn.on.ca" xlink:type="simple">http://www.ohtn.on.ca</ext-link>), and The Ottawa Hospital, Department of Medicine and Division of Infectious Diseases (<ext-link ext-link-type="uri" xlink:href="https://www.ottawahospital.on.ca" xlink:type="simple">https://www.ottawahospital.on.ca</ext-link>). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="0"/>
<table-count count="3"/>
<page-count count="11"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>Data pertaining to people who use drugs are highly sensitive in nature given the criminalization of drug use in the Canadian context. We are therefore not able to make the database publicly available in order to fully protect participants’ confidentiality. To achieve access to the data used in this paper, interested researchers should contact Dr. Claire Kendall at <email xlink:type="simple">ckendall@uottawa.ca</email>. Data are from the PROUD study whose authors may be contacted at <email xlink:type="simple">ckendall@uottawa.ca</email>.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec005" sec-type="intro">
<title>Introduction</title>
<p>Despite major gains in HIV prevention, treatment and care, uptake among people who use drugs (PWUD) remains inequitable [<xref ref-type="bibr" rid="pone.0166942.ref001">1</xref>]. HIV testing among at-risk groups is central to HIV prevention efforts, in particular as the ‘<italic>treatment as prevention</italic>’ paradigm has been shown to improve health outcomes and longevity among those infected, to prevent onward HIV transmission, and to reduce healthcare costs [<xref ref-type="bibr" rid="pone.0166942.ref002">2</xref>–<xref ref-type="bibr" rid="pone.0166942.ref005">5</xref>]. However, PWUD are more likely to receive HIV testing later in the course of infection and some only after developing HIV-related opportunistic infections [<xref ref-type="bibr" rid="pone.0166942.ref006">6</xref>]. This disparity to accessing conventional HIV testing services among PWUD reflects the structural, economic, social, and individual-level barriers experienced by this population [<xref ref-type="bibr" rid="pone.0166942.ref006">6</xref>], including perceived and enacted stigma by health care providers [<xref ref-type="bibr" rid="pone.0166942.ref007">7</xref>].</p>
<p>The recent availability of rapid HIV point-of-care testing (POCT) offers new strategies for improving the uptake of testing among PWUD in both clinical and community-based settings [<xref ref-type="bibr" rid="pone.0166942.ref008">8</xref>,<xref ref-type="bibr" rid="pone.0166942.ref009">9</xref>]. Rapid HIV POCT can reduce anxiety associated with waiting for test results: non-reactive results can be provided at the time of testing, while participants with reactive results can receive on-the-spot linkages to confirmatory testing, support, and treatment [<xref ref-type="bibr" rid="pone.0166942.ref010">10</xref>]. Community-based POCT offers the additional advantage of reaching high risk populations who might not otherwise seek care [<xref ref-type="bibr" rid="pone.0166942.ref011">11</xref>], especially if peers are incorporated into service delivery [<xref ref-type="bibr" rid="pone.0166942.ref006">6</xref>]. Training peer leaders who use (and continue to use) drugs as HIV educators has been shown to be an effective mechanism for HIV prevention among PWUD [<xref ref-type="bibr" rid="pone.0166942.ref012">12</xref>–<xref ref-type="bibr" rid="pone.0166942.ref016">16</xref>]. Furthermore, peer-delivery of testing has been delivered within communities of men who have sex with men (MSM) [<xref ref-type="bibr" rid="pone.0166942.ref011">11</xref>,<xref ref-type="bibr" rid="pone.0166942.ref017">17</xref>,<xref ref-type="bibr" rid="pone.0166942.ref018">18</xref>] and among PWUD with high levels of satisfaction and comfort with confidentiality [<xref ref-type="bibr" rid="pone.0166942.ref019">19</xref>].</p>
<p>The city of Ottawa, Ontario has a large network of people who use both injection and non-injection drugs for a city of its size [<xref ref-type="bibr" rid="pone.0166942.ref020">20</xref>–<xref ref-type="bibr" rid="pone.0166942.ref022">22</xref>]. Despite declines in HIV incidence among the general population, HIV rates among people who use injection drugs in Ottawa remain disproportionately high, with an estimated prevalence of 10% [<xref ref-type="bibr" rid="pone.0166942.ref021">21</xref>]. As 43% of PWUD who were diagnosed with HIV report sharing drug use equipment [<xref ref-type="bibr" rid="pone.0166942.ref021">21</xref>], ongoing transmission remains a significant concern. The PROUD Study is a community-based research project that arose in response to the high rates of HIV among PWUD in Ottawa. In this study, we report a novel community-based peer-administered POCT program developed in collaboration with the local public health authority and communities of PWUD. To the best of our knowledge, and with the exception of the integration of peer educators and testers in a pilot project in Vancouver’s Downtown Eastside [<xref ref-type="bibr" rid="pone.0166942.ref019">19</xref>], there are no other examples of engaging PWUD as testers in community-based HIV testing. Our objective was to elicit the factors associated with the uptake of community-based HIV POCT and to inform models of peer-administered testing among this population.</p>
</sec>
<sec id="sec006" sec-type="materials|methods">
<title>Methods</title>
<sec id="sec007">
<title>Study Design</title>
<p>The Participatory Research in Ottawa: Understanding Drugs (PROUD) Study is a prospective cohort study examining HIV risk among people who use drugs in Ottawa, Ontario and has been described elsewhere [<xref ref-type="bibr" rid="pone.0166942.ref023">23</xref>]. Briefly, between March and December 2013, eligible and consenting participants completed a one-time interviewer-administered iPad-based questionnaire, followed by an opt-in HIV POCT. The quantitative survey included individual-level variables, including socio-demographic information and drug use patterns; interpersonal variables, including sexual history and connections to community; and structural variables, including access and use of harm reduction services, information on housing and homelessness, experiences with the law, and health status and access to health care, including hepatitis C virus (HCV) and HIV testing and treatment. Interviews were administered by a peer or medical student/community ally, depending on interviewer availability and participant comfort. All interviewers received comprehensive training in research ethics, including confidentiality and privacy, and interviewing skills. A cash honorarium (CAN $20.00) was offered after survey completion regardless of whether participants chose to opt-in to HIV POCT.</p>
</sec>
<sec id="sec008">
<title>Study Participants</title>
<p>As previously described in detail [<xref ref-type="bibr" rid="pone.0166942.ref023">23</xref>], potential participants were recruited through peer-based purposive recruitment on the streets and in social service settings frequented by PWUD. Interviews were conducted at our research site, located in Ottawa’s downtown Byward Market area. The space, rented for the purpose of this study, used to be a drop-in centre and was therefore well-known to the community and centrally located. Eligibility criteria included age 16 years or older, having injected or smoked drugs other than marijuana in the past 12 months, and having lived in Ottawa for at least three months.</p>
</sec>
<sec id="sec009">
<title>POCT Intervention</title>
<p>Interviewers (eleven peers, fifteen medical students, and three community allies) received HIV POCT (bioLytical INSTI test) training and certification by Ottawa Public Health. Training included sessions on the following topics: therapeutic relationships and confidentiality, HIV 101, infection control and quality assurance, performing the POCT and result interpretation, and pre- and post-test counseling (including role playing and debriefing). A public health nurse with harm reduction experience was onsite to assist with pre- and post-test counseling, conducting the POCT as well as drawing confirmatory serology for reactive or indeterminate POCT results, and to provide quality assurance, support, referrals and debriefing with peers and medical students. POCT was offered by the survey interviewer upon survey completion. Participants were excluded from POCT if the public health nurse was not present, if they responded ‘yes’ to the question ‘Have you ever tested positive for HIV?’ during the interview-administered questionnaire, or if they declined for other reasons (with reason recorded by interviewers).</p>
<p>This study received ethical approval from The Ottawa Hospital and Ottawa Public Health Research Ethics Boards. All participants provided their written consent to participate in the study and the consent process was approved by both REBs.</p>
</sec>
<sec id="sec010">
<title>Statistical Analysis</title>
<p>We undertook descriptive and univariate analyses [<xref ref-type="bibr" rid="pone.0166942.ref024">24</xref>] to examine which patient characteristics were associated with agreement to undergo HIV POCT, including: drug use patterns; injection practices; equipment sharing practices; access to health care; past experiences with HIV and HCV testing; condom use with sexual partners; sex work; housing status; and experiences with the law. The exposures of interest consisted of those study questions that the investigators and/or peers determined to be potentially associated with perceived need for testing and barriers to accessing care for PWUD. We used chi-square or Fisher exact tests as appropriate for categorical variables and the Wilcoxon rank sum test for continuous variables. Associations are presented as univariate odds ratios with corresponding 95% confidence intervals (CIs).</p>
</sec>
</sec>
<sec id="sec011" sec-type="results">
<title>Results</title>
<p>593 participants were recruited for this analysis: 5 (0.8%) were excluded due to the unavailability of POCT and onsite nursing on the day of their interview and 38 (6.4%) were excluded because of self-reported HIV infection. Of those remaining, 550 (92.7%) were offered HIV POCT: Peers and medical student/allies offered testing to 233 (42.4%) and 317 (57.6%) participants respectively. There was no significant difference in uptake of testing between those offered a peer vs. a non-peer interviewer (83.7% vs. 83.0% respectively, OR = 1.05; 95% CI = 0.67–1.66). The most common reasons for testing refusal were no specific reason provided (n = 21, 22.8%) and recent HIV testing (n = 20, 21.7%). Among participants who consented to POCT, 74 (16.2%) reported never having previous HIV testing.</p>
<p><xref ref-type="table" rid="pone.0166942.t001">Table 1</xref> shows the demographic and drug use characteristics of the participants by uptake of POCT. Participants who agreed to POCT were older (43 vs. 39 years, p = 0.02) and less likely to be female (OR = 0.59; 95% CI = 0.35–0.98). Participants who reported ever injecting drugs were more likely to have consented to testing (OR = 1.71 95% CI = 1.09–2.69), but there were no other significant differences in drug use characteristics between the two groups.</p>
<table-wrap id="pone.0166942.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0166942.t001</object-id>
<label>Table 1</label> <caption><title>Demographic and drug use characteristics associated with uptake of an HIV POCT<xref ref-type="table-fn" rid="t001fn002"><sup>a</sup></xref>.</title></caption>
<alternatives>
<graphic id="pone.0166942.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0166942.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left" rowspan="2">Characteristic</th>
<th align="center" colspan="2">Uptake of an HIV POCT<break/>No. (%) of participants<xref ref-type="table-fn" rid="t001fn003"><sup>b</sup></xref></th>
<th align="left" rowspan="2">OR (95% CI)</th>
</tr>
<tr>
<th align="left">Yes <break/>n = 458</th>
<th align="left">No <break/>n = 92</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left"><bold>Age</bold><xref ref-type="table-fn" rid="t001fn004"><sup>c</sup></xref> <bold>(median, IQR)</bold></td>
<td align="left">43 (34–50)</td>
<td align="left">39 (30–48)</td>
<td align="left"><bold>P-value = 0.02</bold></td>
</tr>
<tr>
<td align="left"><bold>Gender</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Female</td>
<td align="left">87 (77.0)</td>
<td align="left">26 (23.0)</td>
<td align="left"><bold>0.59 (0.35–0.98)</bold></td>
</tr>
<tr>
<td align="left">Male</td>
<td align="left">366 (85.1)</td>
<td align="left">64 (14.9)</td>
<td align="left"><italic>ref</italic></td>
</tr>
<tr>
<td align="left"><bold>Language</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">French</td>
<td align="left">80 (81.6)</td>
<td align="left">18 (18.4)</td>
<td align="left">0.81 (0.45–1.44)</td>
</tr>
<tr>
<td align="left">English</td>
<td align="left">341 (84.6)</td>
<td align="left">62 (15.4)</td>
<td align="left"><italic>ref</italic></td>
</tr>
<tr>
<td align="left"><bold>Education</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Less than high school</td>
<td align="left">228 (83.5)</td>
<td align="left">45 (16.5)</td>
<td align="left">1.04 (0.66–1.62)</td>
</tr>
<tr>
<td align="left">High school and higher</td>
<td align="left">230 (83.0)</td>
<td align="left">47 (17.0)</td>
<td align="left"><italic>ref</italic></td>
</tr>
<tr>
<td align="left"><bold>Ethnicity</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Aboriginal</td>
<td align="left">84 (82.3)</td>
<td align="left">18 (17.7)</td>
<td align="left">0.92 (0.52–1.63)</td>
</tr>
<tr>
<td align="left">Non-Aboriginal</td>
<td align="left">374 (83.5)</td>
<td align="left">74 (16.5)</td>
<td align="left"><italic>ref</italic></td>
</tr>
<tr>
<td align="left"><bold>Neighbourhood of Residence</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Market</td>
<td align="left">197 (81.1)</td>
<td align="left">46 (18.9)</td>
<td align="left">0.73 (0.46–1.16)</td>
</tr>
<tr>
<td align="left">Other Ottawa neighbourhood</td>
<td align="left">240 (85.4)</td>
<td align="left">41 (14.6)</td>
<td align="left"><italic>ref</italic></td>
</tr>
<tr>
<td align="left"><bold>Sexual Identity</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">LGBQ<xref ref-type="table-fn" rid="t001fn005"><sup>d</sup></xref></td>
<td align="left">32 (74.4)</td>
<td align="left">11 (25.6)</td>
<td align="left">0.53 (0.25–1.09)</td>
</tr>
<tr>
<td align="left">Heterosexual</td>
<td align="left">421 (84.7)</td>
<td align="left">76 (15.3)</td>
<td align="left"><italic>ref</italic></td>
</tr>
<tr>
<td align="left"><bold>Ever Injected Drugs</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Yes</td>
<td align="left">300 (86.0)</td>
<td align="left">49 (14.0)</td>
<td align="left"><bold>1.71 (1.09–2.69)</bold></td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">154 (78.2)</td>
<td align="left">43 (21.8)</td>
<td align="left"><italic>ref</italic></td>
</tr>
<tr>
<td align="left"><bold>Injected Drugs in the past 12 months</bold><xref ref-type="table-fn" rid="t001fn006"><sup>e</sup></xref></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Yes</td>
<td align="left">198 (84.6)</td>
<td align="left">36 (15.4)</td>
<td align="left">0.65 (0.33–1.31)</td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">101 (89.4)</td>
<td align="left">12 (10.6)</td>
<td align="left"><italic>ref</italic></td>
</tr>
<tr>
<td align="left"><bold>Injected Cocaine</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Yes</td>
<td align="left">129 (84.3)</td>
<td align="left">24 (15.7)</td>
<td align="left">0.95 (0.45–2.01)</td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">68 (85.0)</td>
<td align="left">12 (15.0)</td>
<td align="left"><italic>ref</italic></td>
</tr>
<tr>
<td align="left"><bold>Injected Crack cocaine</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Yes</td>
<td align="left">99 (86.8)</td>
<td align="left">15 (13.2)</td>
<td align="left">1.38 (0.67–2.84)</td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">96 (82.8)</td>
<td align="left">20 (17.2)</td>
<td align="left"><italic>ref</italic></td>
</tr>
<tr>
<td align="left"><bold>Injected Opiates</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Yes</td>
<td align="left">156 (83.9)</td>
<td align="left">30 (16.1)</td>
<td align="left">0.74 (0.29–1.90)</td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">42 (87.5)</td>
<td align="left">6 (12.5)</td>
<td align="left"><italic>ref</italic></td>
</tr>
<tr>
<td align="left"><bold>Injected Speedball</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Yes</td>
<td align="left">53 (85.5)</td>
<td align="left">9 (14.5)</td>
<td align="left">1.11 (0.49–2.52)</td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">143 (84.1)</td>
<td align="left">27 (15.9)</td>
<td align="left"><italic>ref</italic></td>
</tr>
<tr>
<td align="left"><bold>Injected with other people</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Yes</td>
<td align="left">164 (85.9)</td>
<td align="left">27 (14.1)</td>
<td align="left">1.76 (0.76–4.11)</td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">31 (77.5)</td>
<td align="left">9 (22.5)</td>
<td align="left"><italic>ref</italic></td>
</tr>
<tr>
<td align="left"><bold>Injected in public</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Yes</td>
<td align="left">65 (78.3)</td>
<td align="left">18 (21.7)</td>
<td align="left">0.50 (0.24–1.04)</td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">122 (87.8)</td>
<td align="left">17 (12.2)</td>
<td align="left"><italic>ref</italic></td>
</tr>
<tr>
<td align="left"><bold>Assistance to inject</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Yes</td>
<td align="left">73 (82.0)</td>
<td align="left">16 (18.0)</td>
<td align="left">0.74 (0.36–1.52)</td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">123 (86.0)</td>
<td align="left">20 (14.0)</td>
<td align="left"><italic>ref</italic></td>
</tr>
<tr>
<td align="left"><bold>Used unknown needle</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Yes</td>
<td align="left">32 (88.9)</td>
<td align="left">≤ 5 (11.1)</td>
<td align="left">1.56 (0.52–4.72)</td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">164 (83.7)</td>
<td align="left">32 (16.3)</td>
<td align="left"><italic>ref</italic></td>
</tr>
<tr>
<td align="left"><bold>Injected with used needle</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Yes</td>
<td align="left">43 (84.3)</td>
<td align="left">8 (15.7)</td>
<td align="left">0.98 (0.42–2.31)</td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">153 (84.5)</td>
<td align="left">28 (15.5)</td>
<td align="left"><italic>ref</italic></td>
</tr>
<tr>
<td align="left"><bold>Ever Overdosed</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Yes</td>
<td align="left">193 (83.6)</td>
<td align="left">38 (16.4)</td>
<td align="left">1.03 (0.65–1.63)</td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">261 (83.1)</td>
<td align="left">53 (16.9)</td>
<td align="left"><italic>ref</italic></td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p>OR = odds ratio, CI = confidence interval.</p></fn>
<fn id="t001fn002"><p> <sup>a.</sup> Percentages are calculated on the basis of the sum across each row.</p></fn>
<fn id="t001fn003"><p> <sup>b.</sup> Except where indicated otherwise. Due to ‘no answer’/missing responses, the data for some characteristics do not sum to n = 550.</p></fn>
<fn id="t001fn004"><p> <sup>c.</sup> Median age based on n = 522.</p></fn>
<fn id="t001fn005"><p> <sup>d.</sup> LGBQ stand for Lesbian, Gay, Bisexual and Queer.</p></fn>
<fn id="t001fn006"><p> <sup>e.</sup> All drug use behaviour variables are reported for the previous 12 months unless otherwise specified.</p></fn>
</table-wrap-foot>
</table-wrap>
<p><xref ref-type="table" rid="pone.0166942.t002">Table 2</xref> presents health status and access to health and harm reduction services among those who agreed and did not agree to HIV POCT. No significant differences were found between the two groups.</p>
<table-wrap id="pone.0166942.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0166942.t002</object-id>
<label>Table 2</label> <caption><title>Health characteristics and access to health and harm reduction services associated with uptake of an HIV POCT<xref ref-type="table-fn" rid="t002fn002"><sup>a</sup></xref>.</title></caption>
<alternatives>
<graphic id="pone.0166942.t002g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0166942.t002" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left" rowspan="2">Characteristic</th>
<th align="left" colspan="2">Uptake of an HIV POCT <break/>No. (%) of participants<xref ref-type="table-fn" rid="t002fn003"><sup>b</sup></xref></th>
<th align="left" rowspan="2">OR (95% CI)</th>
</tr>
<tr>
<th align="left">Yes <break/>n = 458</th>
<th align="left">No <break/>n = 92</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left"><bold>Ever trouble accessing new needles</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Yes</td>
<td align="left">33 (84.6)</td>
<td align="left">6 (15.4)</td>
<td align="left">0.96 (0.37–2.50)</td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">171 (85.1)</td>
<td align="left">30 (14.9)</td>
<td align="left"><italic>ref</italic></td>
</tr>
<tr>
<td align="left"><bold>Accessed addiction treatment past 12 months</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Yes</td>
<td align="left">174 (86.1)</td>
<td align="left">28 (13.9)</td>
<td align="left">1.36 (0.84–2.22)</td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">278 (82.0)</td>
<td align="left">61 (18.0)</td>
<td align="left"><italic>ref</italic></td>
</tr>
<tr>
<td align="left"><bold>Ever received support from a peer worker</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Yes</td>
<td align="left">182 (85.4)</td>
<td align="left">31 (14.6)</td>
<td align="left">1.29 (0.80–2.07)</td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">273 (82.0)</td>
<td align="left">60 (18.0)</td>
<td align="left"><italic>ref</italic></td>
</tr>
<tr>
<td align="left"><bold>Ever received support from other organizations</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Yes</td>
<td align="left">273 (84.0)</td>
<td align="left">52 (16.0)</td>
<td align="left">1.10 (0.69–1.73)</td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">182 (82.7)</td>
<td align="left">38 (17.3)</td>
<td align="left"><italic>ref</italic></td>
</tr>
<tr>
<td align="left"><bold>Attempted suicide past 12 months</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Yes</td>
<td align="left">39 (95.1)</td>
<td align="left">≤ 5 (4.9)</td>
<td align="left">4.00 (0.95–16.87)</td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">410 (83.0)</td>
<td align="left">84 (17.0)</td>
<td align="left"><italic>ref</italic></td>
</tr>
<tr>
<td align="left"><bold>Sought care for health issue in past 12 months</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Yes</td>
<td align="left">270 (85.4)</td>
<td align="left">46 (14.6)</td>
<td align="left">1.42 (0.90–2.23)</td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">186 (80.5)</td>
<td align="left">45 (19.5)</td>
<td align="left"><italic>ref</italic></td>
</tr>
<tr>
<td align="left"><bold>Sought care from a hospital or ER in past 12 months</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Yes</td>
<td align="left">183 (86.7)</td>
<td align="left">28 (13.3)</td>
<td align="left">1.35 (0.71–2.58)</td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">87 (82.9)</td>
<td align="left">18 (17.1)</td>
<td align="left"><italic>ref</italic></td>
</tr>
<tr>
<td align="left"><bold>Have regular doctor</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Yes</td>
<td align="left">243 (85.6)</td>
<td align="left">41 (14.4)</td>
<td align="left">1.38 (0.88–2.18)</td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">214 (81.1)</td>
<td align="left">50 (18.9)</td>
<td align="left"><italic>ref</italic></td>
</tr>
<tr>
<td align="left"><bold>Ever tested for HCV</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Yes</td>
<td align="left">378 (84.4)</td>
<td align="left">70 (15.6)</td>
<td align="left">1.18 (0.63–2.22)</td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">64 (82.0)</td>
<td align="left">14(18.0)</td>
<td align="left"><italic>ref</italic></td>
</tr>
<tr>
<td align="left"><bold>Result of last HCV test</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Positive</td>
<td align="left">160 (86.0)</td>
<td align="left">26 (14.0)</td>
<td align="left">1.28 (0.75–2.18)</td>
</tr>
<tr>
<td align="left">Negative</td>
<td align="left">193 (82.8)</td>
<td align="left">40 (17.2)</td>
<td align="left"><italic>ref</italic></td>
</tr>
<tr>
<td align="left"><bold>Know that can be charged for not disclosing HIV status to partners</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Yes</td>
<td align="left">397 (83.4)</td>
<td align="left">79 (16.6)</td>
<td align="left">1.04 (0.53–2.03)</td>
</tr>
<tr>
<td align="left">Other (No, Maybe, Don’t know)</td>
<td align="left">58 (82.9)</td>
<td align="left">12 (17.1)</td>
<td align="left"><italic>ref</italic></td>
</tr>
<tr>
<td align="left"><bold>Ever tested for HIV</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Yes</td>
<td align="left">369 (82.2)</td>
<td align="left">80 (17.8)</td>
<td align="left">0.62 (0.31–1.26)</td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">74 (88.1)</td>
<td align="left">10 (11.9)</td>
<td align="left"><italic>ref</italic></td>
</tr>
<tr>
<td align="left"><bold>Tested for HIV in the past 12 months</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Yes</td>
<td align="left">187 (82.7)</td>
<td align="left">39 (17.3)</td>
<td align="left">1.06 (0.63–1.77)</td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">145 (81.9)</td>
<td align="left">32 (18.1)</td>
<td align="left"><italic>ref</italic></td>
</tr>
<tr>
<td align="left"><bold>Worried about HIV exposure</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Yes</td>
<td align="left">191 (85.7)</td>
<td align="left">32 (14.3)</td>
<td align="left">1.37 (0.85–2.21)</td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">239 (81.3)</td>
<td align="left">55 (18.7)</td>
<td align="left"><italic>ref</italic></td>
</tr>
<tr>
<td align="left"><bold>Who administered HIV test</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Peer</td>
<td align="left">195(83.7)</td>
<td align="left">38 (16.3)</td>
<td align="left">1.05 (0.67–1.66)</td>
</tr>
<tr>
<td align="left">Other (medical student, nurse, RA)</td>
<td align="left">263 (83.0)</td>
<td align="left">54 (17.0)</td>
<td align="left"><italic>ref</italic></td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t002fn001"><p>OR = odds ratio, CI = confidence interval</p></fn>
<fn id="t002fn002"><p> <sup>a.</sup> Percentages are calculated on the basis of the sum across each row</p></fn>
<fn id="t002fn003"><p> <sup>b.</sup> Except when indicated otherwise. Due to ‘no answer’/missing responses, the data for some characteristics do not sum to n = 550.</p></fn>
</table-wrap-foot>
</table-wrap>
<p><xref ref-type="table" rid="pone.0166942.t003">Table 3</xref> shows variables related to structural risks including associations with the law, sex work, and housing status. Participants who reported having engaged in sex work in the past 12 months were significantly less likely to agree to HIV POCT (OR = 0.48; 95% CI = 0.25–0.92), whereas participants who reported having spent overnight or longer in jail in the past 12 months or to have consumed drugs in jail were significantly more likely to agree to testing (OR = 1.71; 95% CI = 1.05 to 2.78) and (OR = 2.43; 95% CI = 1.07–5.52), respectively.</p>
<table-wrap id="pone.0166942.t003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0166942.t003</object-id>
<label>Table 3</label> <caption><title>Legal system encounters, sex work, and housing characteristics associated with uptake of an HIV POCT<xref ref-type="table-fn" rid="t003fn002"><sup>a</sup></xref>.</title></caption>
<alternatives>
<graphic id="pone.0166942.t003g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0166942.t003" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left" rowspan="2">Characteristic</th>
<th align="left" colspan="2">Uptake of an HIV POCT<break/>No. (%) of participants<xref ref-type="table-fn" rid="t003fn003"><sup>b</sup></xref></th>
<th align="left" rowspan="2">OR (95% CI)</th>
</tr>
<tr>
<th align="left">Yes <break/>n = 458</th>
<th align="left">No <break/>n = 92</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left"><bold>Sex partner in past 12 months</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Yes</td>
<td align="left">338 (84.9)</td>
<td align="left">60 (15.1)</td>
<td align="left">1.37 (0.84–2.25)</td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">115 (80.4)</td>
<td align="left">28 (19.6)</td>
<td align="left"><italic>ref</italic></td>
</tr>
<tr>
<td align="left"><bold>Condom use in past 12 months</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Not always</td>
<td align="left">223 (85.4)</td>
<td align="left">38 (14.6)</td>
<td align="left">1.12 (0.36–3.44)</td>
</tr>
<tr>
<td align="left">Always</td>
<td align="left">21 (84.0)</td>
<td align="left">≤ 5 (16.0)</td>
<td align="left"><italic>ref</italic></td>
</tr>
<tr>
<td align="left"><bold>Gave drugs, $, gifts for sex</bold><xref ref-type="table-fn" rid="t003fn004"><sup>c</sup></xref></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Yes</td>
<td align="left">63 (85.1)</td>
<td align="left">11(14.9)</td>
<td align="left">1.02 (0.41–2.52)</td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">62 (84.9)</td>
<td align="left">11 (15.1)</td>
<td align="left"><italic>ref</italic></td>
</tr>
<tr>
<td align="left"><bold>Engaged in sex work</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Yes</td>
<td align="left">44 (74.6)</td>
<td align="left">15 (25.4)</td>
<td align="left"><bold>0.48 (0.25–0.92)</bold></td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">343 (86.0)</td>
<td align="left">56 (14.0)</td>
<td align="left"><italic>ref</italic></td>
</tr>
<tr>
<td align="left"><bold>Current place of residence</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Unstably housed</td>
<td align="left">277 (82.2)</td>
<td align="left">60 (17.8)</td>
<td align="left">0.80 (0.50–1.28)</td>
</tr>
<tr>
<td align="left">Stably housed</td>
<td align="left">179 (85.2)</td>
<td align="left">31 (14.8)</td>
<td align="left"><italic>ref</italic></td>
</tr>
<tr>
<td align="left"><bold>Ever been homeless</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Yes</td>
<td align="left">405 (83.2)</td>
<td align="left">82 (16.8)</td>
<td align="left">0.85 (0.41–1.80)</td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">52 (85.3)</td>
<td align="left">9 (14.7)</td>
<td align="left"><italic>ref</italic></td>
</tr>
<tr>
<td align="left"><bold>Homeless for at least one night in past 12 months</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Yes</td>
<td align="left">345 (85.5)</td>
<td align="left">68 (16.5)</td>
<td align="left">1.08 (0.65–1.80)</td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">113 (82.5)</td>
<td align="left">24 (17.5)</td>
<td align="left"><italic>ref</italic></td>
</tr>
<tr>
<td align="left"><bold>Ever redzoned</bold><xref ref-type="table-fn" rid="t003fn005"><sup>d</sup></xref></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Yes</td>
<td align="left">177 (85.1)</td>
<td align="left">31 (14.9)</td>
<td align="left">1.21 (0.75–1.95)</td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">278 (82.5)</td>
<td align="left">59 (17.5)</td>
<td align="left"><italic>ref</italic></td>
</tr>
<tr>
<td align="left"><bold>Stopped/searched by police</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Yes</td>
<td align="left">302 (84.1)</td>
<td align="left">57 (15.88)</td>
<td align="left">1.09 (0.68–1.76)</td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">155 (82.9)</td>
<td align="left">32 (17.1)</td>
<td align="left"><italic>ref</italic></td>
</tr>
<tr>
<td align="left"><bold>Kept overnight or longer in jail</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Yes</td>
<td align="left">202 (87.8)</td>
<td align="left">28 (12.2)</td>
<td align="left"><bold>1.71 (1.05–2.78)</bold></td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">253 (80.8)</td>
<td align="left">60 (19.2)</td>
<td align="left"><italic>ref</italic></td>
</tr>
<tr>
<td align="left"><bold>Consumed drugs in jail</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Yes</td>
<td align="left">116 (92.1)</td>
<td align="left">10 (7.9)</td>
<td align="left"><bold>2.43 (1.07–5.52)</bold></td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">86 (82.7)</td>
<td align="left">18 (17.3)</td>
<td align="left"><italic>ref</italic></td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t003fn001"><p>OR = odds ratio, CI = confidence interval.</p></fn>
<fn id="t003fn002"><p> <sup>a.</sup> Percentages are calculated on the basis of the sum across each row.</p></fn>
<fn id="t003fn003"><p> <sup>b.</sup> Except where indicated otherwise. Because of ‘no answer’/missing responses, the data for some characteristics do not sum to n = 550.</p></fn>
<fn id="t003fn004"><p> <sup>c.</sup> Variables are reported for the previous 12 months unless otherwise specified.</p></fn>
<fn id="t003fn005"><p> <sup>d.</sup> Redzones were defined as any geographical area or neighborhood where law enforcement had restricted the participant’s movement.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>Only one POCT resulted as reactive and was subsequently confirmed as HIV positive with confirmatory serology.</p>
</sec>
<sec id="sec012" sec-type="conclusions">
<title>Discussion</title>
<p>This study demonstrates the high uptake of a community-based HIV POCT model for PWUD. In order to optimally reach people who use drugs with HIV prevention efforts, our findings support the expansion of novel community-based methods for providing testing, including peer-administered approaches. To the best of our knowledge, and with the exception of the integration of peer educators and testers in a pilot project in Vancouver’s Downtown Eastside [<xref ref-type="bibr" rid="pone.0166942.ref019">19</xref>], there are no other examples of engaging PWUD as testers in community-based HIV testing.</p>
<p>We found no difference in uptake of testing when HIV POCT was offered by a peer versus a non-peer interviewer, supporting previous work demonstrating that people at risk may be comfortable with having POCT administered by peers in a community setting. As has been demonstrated among MSM communities [<xref ref-type="bibr" rid="pone.0166942.ref011">11</xref>], peer testers in our study were able to handle tests, deliver non-reactive results, and provide pre- and post-test counseling in a manner that resonated with participants. Onsite nursing supervision provided peers with support for all aspects of HIV POCT, including: prompting on the POCT process; completing documentation; and guidance to identify when nurse involvement was appropriate. Furthermore, we successfully reached participants who had not previously been tested for HIV, thus providing new opportunities for HIV prevention education and counseling. Previous research has demonstrated that peer-delivered messaging has the potential to increase the interpretation and uptake of HIV prevention information by PWUD, providing value above POCT alone [<xref ref-type="bibr" rid="pone.0166942.ref025">25</xref>,<xref ref-type="bibr" rid="pone.0166942.ref026">26</xref>].</p>
<p>While there were few differences in characteristics among those who agreed and did not agree to HIV POCT, a few key findings emerged. There was high uptake of our community-based testing model among PWUD at high risk of HIV infection, including those who use injection drugs [<xref ref-type="bibr" rid="pone.0166942.ref027">27</xref>] and those reporting drug use while incarcerated [<xref ref-type="bibr" rid="pone.0166942.ref028">28</xref>]. These findings corroborate those of a Baltimore study that found high opt-in rates for onsite rapid HIV testing at probation and parole offices [<xref ref-type="bibr" rid="pone.0166942.ref010">10</xref>]. In our study, testing followed an hour-long interview, and honoraria were provided regardless of whether or not testing occurred, thus testing rates likely reflect a strong desire to be tested among individuals who have previously been incarcerated. However, low agreement for testing among female participants and those involved in sex work suggest the need for more targeted approaches to reach populations who may face multiple sources of stigma and experience increased barriers to accessing HIV testing and treatment services [<xref ref-type="bibr" rid="pone.0166942.ref029">29</xref>]. More specialized approaches, including female only services [<xref ref-type="bibr" rid="pone.0166942.ref029">29</xref>,<xref ref-type="bibr" rid="pone.0166942.ref030">30</xref>], should be explored to better reach these groups.</p>
<p>There are several limitations to our study. First, we used purposive sampling, which allowed us to target recruitment towards those facing multiple and intersecting oppressions among the study participants. However, our findings may not be applicable to all populations of PWUD. Second, characteristics are based on self-report to highly sensitive questions, which may have contributed to social desirability bias and an underreporting of high-risk practices. Third, it is possible that those who declined testing did so not because of the absence or presence of characteristics found to be associated with uptake of testing, but because they were aware of their positive status or had very recent testing, which was not fully elicited by our study. It is also possible that characteristics of testers other than peer or student status influenced uptake. For example, peers tended to be older and male, whereas medical students were younger and female. Participants were provided an option for who would conduct the test when possible, but availability may have also contributed to the ultimate uptake of HIV POCT. Finally, only one new reactive POCT was determined among participants. It is possible that our recruited population was already served by other testing and care services, or that HIV rates may be higher among those who did not agree to testing.</p>
<p>As we move towards scaling up HIV testing opportunities among at-risk groups, there is a need to develop novel models of community-based testing that draw on the strengths of peer involvement to reach individuals who may not seek testing and treatment in conventional health care settings. The PROUD study has shown high uptake of community-based and peer-administered HIV POCT among PWUD at highest risk of HIV acquisition. Future community and peer-based approaches should be implemented towards specific at-risk communities, including women and those involved in sex work, who may face challenges in accessing conventional clinic-based HIV-testing and treatment services.</p>
</sec>
</body>
<back>
<ack>
<p>We would like to thank everyone who provided their expertise and time to this project, particularly our PROUD Community Advisory Committee members: Kelly F., Chris D., Dan M., Rick S., Tyler P., Hana D., Alana M., Tarah H., Caleb C., Fred C., Sean L., June C., Christine L., and Gilles D. (lead author for the committee: Mark W. Tyndall (<email xlink:type="simple">Mark.Tyndall@bccdc.ca</email>)); Ottawa Public Health for their support of the HIV POCT component of the project; our medical student volunteers; and all of our community partners. We would also like to thank all of the individuals who participated in the study.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pone.0166942.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Grigoryan</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Hall</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Durant</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Wei</surname> <given-names>X</given-names></name>. <article-title>Late HIV diagnosis and determinants of progression to AIDS or death after HIV diagnosis among injection drug users, 33 US States, 1996–2004</article-title>. <source>PLoS ONE</source> <year>2009</year>;<volume>4</volume>:<fpage>e4445</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0004445" xlink:type="simple">10.1371/journal.pone.0004445</ext-link></comment> <object-id pub-id-type="pmid">19214229</object-id></mixed-citation></ref>
<ref id="pone.0166942.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Montaner</surname> <given-names>JSG</given-names></name>, <name name-style="western"><surname>Hogg</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Wood</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Kerr</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Tyndall</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Levy</surname> <given-names>AR</given-names></name>, <etal>et al</etal>. <article-title>The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic</article-title>. <source>Lancet</source> <year>2006</year>;<volume>368</volume>:<fpage>531</fpage>–<lpage>536</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0140-6736(06)69162-9" xlink:type="simple">10.1016/S0140-6736(06)69162-9</ext-link></comment> <object-id pub-id-type="pmid">16890841</object-id></mixed-citation></ref>
<ref id="pone.0166942.ref003"><label>3</label><mixed-citation publication-type="book" xlink:type="simple"><collab>World Health Organization (WHO)</collab>. <source>Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach</source>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>WHO</publisher-name>; <year>2013</year>. <ext-link ext-link-type="uri" xlink:href="http://www.who.int/hiv/pub/guidelines/arv2013/en/" xlink:type="simple">http://www.who.int/hiv/pub/guidelines/arv2013/en/</ext-link> (Accessed 12 Feb 2015).</mixed-citation></ref>
<ref id="pone.0166942.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Girardi</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Sabin</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Monforte</surname> <given-names>AD</given-names></name>. <article-title>Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing</article-title>. <source>J Acquir Immune Defic Syndr</source> <year>2007</year>;<volume>46</volume>(<issue>Suppl 1</issue>):<fpage>S3</fpage>–<lpage>8</lpage>.</mixed-citation></ref>
<ref id="pone.0166942.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Johnston</surname> <given-names>KM</given-names></name>, <name name-style="western"><surname>Levy</surname> <given-names>AR</given-names></name>, <name name-style="western"><surname>Lima</surname> <given-names>VD</given-names></name>, <name name-style="western"><surname>Hogg</surname> <given-names>RS</given-names></name>, <name name-style="western"><surname>Tyndall</surname> <given-names>MW</given-names></name>, <name name-style="western"><surname>Gustafson</surname> <given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Expanding access to HAART: a cost-effective approach for treating and preventing HIV</article-title>. <source>AIDS</source> <year>2010</year>;<volume>24</volume>:<fpage>1929</fpage>–<lpage>1935</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/QAD.0b013e32833af85d" xlink:type="simple">10.1097/QAD.0b013e32833af85d</ext-link></comment> <object-id pub-id-type="pmid">20588171</object-id></mixed-citation></ref>
<ref id="pone.0166942.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Marwick</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Ti</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Callon</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Feng</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Wood</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Kerr</surname> <given-names>T</given-names></name>. <article-title>Willingness to engage in peer-delivered HIV voluntary counselling and testing among people who inject drugs in a Canadian setting</article-title>. <source>J Epidemiol Community Health</source> <year>2014</year>;<volume>68</volume>:<fpage>675</fpage>–<lpage>678</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/jech-2013-203707" xlink:type="simple">10.1136/jech-2013-203707</ext-link></comment> <object-id pub-id-type="pmid">24700578</object-id></mixed-citation></ref>
<ref id="pone.0166942.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wood</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Kerr</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Tyndall</surname> <given-names>MW</given-names></name>, <name name-style="western"><surname>Montaner</surname> <given-names>JS</given-names></name>. <article-title>A review of barriers and facilitators of HIV treatment among injection drug users</article-title>. <source>AIDS</source> <year>2008</year>;<volume>22</volume>:<fpage>1247</fpage>–<lpage>56</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/QAD.0b013e3282fbd1ed" xlink:type="simple">10.1097/QAD.0b013e3282fbd1ed</ext-link></comment> <object-id pub-id-type="pmid">18580603</object-id></mixed-citation></ref>
<ref id="pone.0166942.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bowles</surname> <given-names>KE</given-names></name>, <name name-style="western"><surname>Clark</surname> <given-names>HA</given-names></name>, <name name-style="western"><surname>Tai</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Sullivan</surname> <given-names>PS</given-names></name>, <name name-style="western"><surname>Song</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Tsang</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Implementing rapid HIV testing in outreach and community settings: results from an advancing HIV prevention demonstration project conducted in seven US cities</article-title>. <source>Public Health Reports</source> <year>2008</year>;<volume>123</volume>:<fpage>78</fpage>–<lpage>85</lpage>.</mixed-citation></ref>
<ref id="pone.0166942.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ruutel</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Ustina</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Parker</surname> <given-names>RD</given-names></name>. <article-title>Piloting HIV rapid testing in community-based settings in Estonia</article-title>. <source>Scandinavian Journal of Public Health</source> <year>2012</year>;<volume>40</volume>:<fpage>629</fpage>–<lpage>633</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1177/1403494812458987" xlink:type="simple">10.1177/1403494812458987</ext-link></comment> <object-id pub-id-type="pmid">23012323</object-id></mixed-citation></ref>
<ref id="pone.0166942.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gordon</surname> <given-names>MS</given-names></name>, <name name-style="western"><surname>Kinlock</surname> <given-names>TW</given-names></name>, <name name-style="western"><surname>McKenzie</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Wilson</surname> <given-names>ME</given-names></name>, <name name-style="western"><surname>Rich</surname> <given-names>JD</given-names></name>. <article-title>Rapid HIV Testing for Individuals on Probation/Parole: Outcomes of an Intervention Trial</article-title>. <source>AIDS Behav</source> <year>2013</year>;<volume>17</volume>:<fpage>2022</fpage>–<lpage>2030</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s10461-013-0456-6" xlink:type="simple">10.1007/s10461-013-0456-6</ext-link></comment> <object-id pub-id-type="pmid">23536140</object-id></mixed-citation></ref>
<ref id="pone.0166942.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Champenois</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Le Gall</surname> <given-names>J-M</given-names></name>, <name name-style="western"><surname>Jacquemin</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Jean</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Martin</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Rios</surname> <given-names>L</given-names></name>, <etal>et al</etal>. <article-title>ANRS-COM’TEST: Description of a community-based HIV testing intervention in non-medical settings for men who have sex with men</article-title>. <source>BMJ Open</source> <year>2012</year>;<volume>2</volume>:<fpage>e000693</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/bmjopen-2011-000693" xlink:type="simple">10.1136/bmjopen-2011-000693</ext-link></comment> <object-id pub-id-type="pmid">22466158</object-id></mixed-citation></ref>
<ref id="pone.0166942.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Latkin</surname> <given-names>CA</given-names></name>. <article-title>Outreach in natural settings: the use of peer leaders for HIV prevention among injecting drug users' networks</article-title>. <source>Public Health Reports</source> <year>1998</year>;<volume>113</volume>:<fpage>151</fpage>–<lpage>159</lpage>. <object-id pub-id-type="pmid">9722820</object-id></mixed-citation></ref>
<ref id="pone.0166942.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tobin</surname> <given-names>KE</given-names></name>, <name name-style="western"><surname>Kuramoto</surname> <given-names>SJ</given-names></name>, <name name-style="western"><surname>Davey-Rothwell</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Latkin</surname> <given-names>CA</given-names></name>. <article-title>The STEP into action study: a peer-based, personal risk network focused HIV prevention intervention with injection drug users in Baltimore, Maryland</article-title>. <source>Addiction</source> <year>2011</year>;<volume>106</volume>:<fpage>366</fpage>–<lpage>375</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1360-0443.2010.03146.x" xlink:type="simple">10.1111/j.1360-0443.2010.03146.x</ext-link></comment> <object-id pub-id-type="pmid">21054614</object-id></mixed-citation></ref>
<ref id="pone.0166942.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rhodes</surname> <given-names>T</given-names></name>. <article-title>The risk environment: a framework for understanding and reducing drug-related harm</article-title>. <source>Int J Drug Pol</source> <year>2002</year>;<volume>13</volume>:<fpage>85</fpage>–<lpage>94</lpage>.</mixed-citation></ref>
<ref id="pone.0166942.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Davidson</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Page</surname> <given-names>K</given-names></name>. <article-title>Research participation as work: comparing the perspectives of researchers and economically marginalized populations</article-title>. <source>Am J Public Health</source> <year>2012</year>;<volume>102</volume>:<fpage>1254</fpage>–<lpage>1259</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2105/AJPH.2011.300418" xlink:type="simple">10.2105/AJPH.2011.300418</ext-link></comment> <object-id pub-id-type="pmid">22594754</object-id></mixed-citation></ref>
<ref id="pone.0166942.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Adam</surname> <given-names>BD</given-names></name>. <article-title>Epistemic fault lines in biomedical and social approaches to HIV prevention</article-title>. <source>Journal of International AIDS Society</source> <year>2011</year>;<volume>14</volume>(<issue>Suppl 2</issue>):<fpage>S2</fpage>. <ext-link ext-link-type="uri" xlink:href="http://www.jiasociety.org/content/14/S2/S2" xlink:type="simple">http://www.jiasociety.org/content/14/S2/S2</ext-link></mixed-citation></ref>
<ref id="pone.0166942.ref017"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Pujol F, Meulbroek M, Saz J, Taboada H, Montilla E, Ditzel E, et al. BCN checkpoint: three-year experience (2007–2009) of a community based centre for MSM in Barcelona (Spain) shows high effectiveness in HIV detection. International AIDS Conference. Vienna, Austria: International AIDS Society 2010:18–23.</mixed-citation></ref>
<ref id="pone.0166942.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yan</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Wei</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Xu</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Yang</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>A peer-led, community-based rapid HIV testing intervention among untested Men Who Have Sex With Men in China: an operational model for expansion of HIV testing and linkage to care</article-title>. <source>Sex Transm Infect</source> <year>2014</year>;<volume>90</volume>:<fpage>388</fpage>–<lpage>393</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/sextrans-2013-051397" xlink:type="simple">10.1136/sextrans-2013-051397</ext-link></comment> <object-id pub-id-type="pmid">24926040</object-id></mixed-citation></ref>
<ref id="pone.0166942.ref019"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Tolson M. Seek and Treat to Optimally Prevent (S.T.O.P.)HIV/AIDS: Community Engagement Report. Vancouver: Vancouver Coastal Health; 2011.</mixed-citation></ref>
<ref id="pone.0166942.ref020"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Ottawa Public Health. Substance Misuse in Ottawa: Technical Report. March 2013. Ottawa (ON): Ottawa Public Health; 2013.</mixed-citation></ref>
<ref id="pone.0166942.ref021"><label>21</label><mixed-citation publication-type="book" xlink:type="simple"><collab>Ottawa Public Health</collab>. <source>Overdoes and HIV and hepatitis C infection among people in Ottawa who use drugs</source>. <month>January</month> <year>2014</year>. <publisher-loc>Ottawa (ON)</publisher-loc>: <publisher-name>Ottawa Public Health</publisher-name>; 2014.</mixed-citation></ref>
<ref id="pone.0166942.ref022"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Remis R, Swantee C, Liu J. Report on HIV/AIDS in Ontario 2009. June 2012. <ext-link ext-link-type="uri" xlink:href="http://www.ohemu.utoronto.ca/doc/PHERO2009_report_final.pdf" xlink:type="simple">http://www.ohemu.utoronto.ca/doc/PHERO2009_report_final.pdf</ext-link> (Accessed 12 Feb 2015).</mixed-citation></ref>
<ref id="pone.0166942.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lazarus</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Shaw</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>LeBlanc</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Martin</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Marshall</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Weersink</surname> <given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Establishing a community-based participatory research partnership among people who use drugs in Ottawa: the PROUD cohort study</article-title>. <source>Harm Reduction Journal</source> <year>2014</year>;<volume>11</volume>:<fpage>26</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1477-7517-11-26" xlink:type="simple">10.1186/1477-7517-11-26</ext-link></comment> <object-id pub-id-type="pmid">25307356</object-id></mixed-citation></ref>
<ref id="pone.0166942.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Walter</surname> <given-names>SD</given-names></name>. <article-title>Choice of effect measure for epidemiological data</article-title>. <source>J Clin Epidemiol</source> <year>2000</year>;<volume>53</volume>(<issue>9</issue>):<fpage>931</fpage>–<lpage>9</lpage>. <object-id pub-id-type="pmid">11004419</object-id></mixed-citation></ref>
<ref id="pone.0166942.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Coupland</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Maher</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Enriquez</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Le</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Pacheco</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Pham</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Clients or colleagues? Reflections on the process of participatory action research with young injecting drug users</article-title>. <source>Int J Drug Pol</source> <year>2005</year>;<volume>16</volume>:<fpage>191</fpage>–<lpage>198</lpage>.</mixed-citation></ref>
<ref id="pone.0166942.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dickson-Gomez</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Weeks</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Martinez</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Convey</surname> <given-names>M</given-names></name>. <article-title>Times and places: process evaluation of a peer-led HIV prevention intervention</article-title>. <source>Subst Use Misuse</source> <year>2006</year>;<volume>41</volume>:<fpage>669</fpage>–<lpage>690</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1080/10826080500411403" xlink:type="simple">10.1080/10826080500411403</ext-link></comment> <object-id pub-id-type="pmid">16603454</object-id></mixed-citation></ref>
<ref id="pone.0166942.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lauplans</surname> <given-names>KB</given-names></name>, <name name-style="western"><surname>Embril</surname> <given-names>JM</given-names></name>. <article-title>Reducing the adverse impact of injection drug use in Canada</article-title>. <source>Can J Infect Dis Med Microbiol</source> <year>2012</year>;<volume>23</volume>:<fpage>106</fpage>–<lpage>107</lpage>. <object-id pub-id-type="pmid">23997772</object-id></mixed-citation></ref>
<ref id="pone.0166942.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kouyoumdjian</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Schuler</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Matheson</surname> <given-names>FI</given-names></name>, <name name-style="western"><surname>Hwang</surname> <given-names>SW</given-names></name>. <article-title>Health status of prisoners in Canada Narrative review</article-title>. <source>Canadian Family Physician</source> <year>2016</year>;<volume>62</volume>(<issue>3</issue>):<fpage>215</fpage>–<lpage>22</lpage>. <object-id pub-id-type="pmid">27427562</object-id></mixed-citation></ref>
<ref id="pone.0166942.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lazarus</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Deering</surname> <given-names>KN</given-names></name>, <name name-style="western"><surname>Nabess</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Gibson</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Tyndall</surname> <given-names>MW</given-names></name>, <name name-style="western"><surname>Shannon</surname> <given-names>K</given-names></name>. <article-title>Occupational stigma as a primary barrier to health care for street-based sex workers in Canada</article-title>. <source>Culture, Health &amp; Sexuality</source> <year>2012</year>;<volume>14</volume>:<fpage>139</fpage>–<lpage>150</lpage>.</mixed-citation></ref>
<ref id="pone.0166942.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kim</surname> <given-names>SR</given-names></name>, <name name-style="western"><surname>Goldenberg</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Duff</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Nguyen</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Gibson</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Shannon</surname> <given-names>K</given-names></name>. <article-title>Uptake of a women-only, sex-work-specific drop-in center and links with sexual and reproductive health care for sex workers</article-title>. <source>International Journal of Gynecology &amp; Obstetrics</source> <year>2015</year>;<volume>128</volume>:<fpage>201</fpage>–<lpage>205</lpage>.</mixed-citation></ref>
</ref-list>
</back>
</article>